Market Overview

The Global Bipolar Disorders Treatment Market was valued at USD 9,351.2 million in 2023 and is expected to reach USD 15,017.3 million by 2031 while growing at a CAGR of 6.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global bipolar disorders treatment market growth. Treatment for bipolar disorder usually encompasses a blend of medication, psychotherapy, lifestyle changes, and occasionally hospitalization for severe cases, aiming to stabilize mood fluctuations, minimize episode frequency and intensity, and enhance overall quality of life.

The escalating prevalence of Bipolar Disorder, coupled with continuous research and development endeavors, fuels the discovery of new drugs and treatment modalities, such as innovative mood stabilizers, antipsychotics, and adjunctive therapies, thereby propelling the bipolar disorder treatment market. Nevertheless, the market's growth is impeded by the high cost of treatment and the adverse effects of medications.

Furthermore, the global bipolar disorders treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Drug Class Analysis

The Global Bipolar Disorders Treatment Market is segmented among Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others, based on Drug Class. In 2023, Antipsychotics accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Distribution Channel Analysis

The Global Bipolar Disorders Treatment Market is segmented among Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, based on Distribution Channel. In 2023, Hospital Pharmacies accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Bipolar Disorders Treatment Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are AbbVie Inc., Allergan PLC, AstraZeneca Plc, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals Inc., Novartis AG, Otsuka Holdings Co. Ltd, and Pfizer Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Bipolar Disorders Treatment Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Bipolar Disorders Treatment Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Bipolar Disorders Treatment Market Segmentation, By Drug Class

• Global Bipolar Disorders Treatment Market Share Analysis, By Drug Class

• Global Bipolar Disorders Treatment Market Growth Analysis, By Drug Class

• Global Bipolar Disorders Treatment Market Trends, By Drug Class

o Antipsychotics

o Antidepressants

o Mood Stabilizers

o Anti-anxiety Drugs and Others

6. Global Bipolar Disorders Treatment Market Segmentation, By Distribution Channel

• Global Bipolar Disorders Treatment Market Share Analysis, By Distribution Channel

• Global Bipolar Disorders Treatment Market Growth Analysis, By Distribution Channel

• Global Bipolar Disorders Treatment Market Trends, By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

7. Global Bipolar Disorders Treatment Market Segmentation, By Region

• Global Bipolar Disorders Treatment Market Share Analysis, By Region

• Global Bipolar Disorders Treatment Market Growth Analysis, By Region

• Global Bipolar Disorders Treatment Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• AbbVie Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Allergan PLC

• AstraZeneca Plc

• Eli Lilly and Company

• GlaxoSmithKline Plc

• Janssen Pharmaceuticals Inc.

• Novartis AG

• Otsuka Holdings Co. Ltd

• Pfizer Inc.

*Similar analysis will be provided for each company listed above.